Popular Pages

Share

Common Micropakine Side Effects


The most commonly reported Micropakine side effects (click to view or check a box to report):

Epilepsy (9)
Convulsion (6)
C-reactive Protein Increased (3)
Pancytopenia (3)
Hallucination (3)
Pyrexia (3)
Rash Morbilliform (3)
Systemic Inflammatory Response Syndrome (3)
Pancreatitis Acute (2)
Reticulocyte Count Increased (2)
Overdose (2)
Accidental Overdose (2)
Vomiting (2)
Apathy (2)
Somnolence (2)
Sleep Disorder (2)
Speech Disorder (2)
Status Epilepticus (2)
Treatment Noncompliance (2)
Unevaluable Event (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Micropakine Side Effects Reported to FDA



Micropakine Side Effect Report#9926226
Delirium, Menstruation Irregular, Overweight, Mental Disorder, Hallucination, Sleep Disorder, Incoherent, Polycystic Ovaries, Menstrual Disorder
This is a report of a 19-year-old female patient (weight: NA) from FR, suffering from the following health symptoms/conditions: epilepsy, who was treated with Micropakine (dosage: NA, start time: 2013), combined with: NA. and developed a serious reaction and side effect(s): Delirium, Menstruation Irregular, Overweight, Mental Disorder, Hallucination, Sleep Disorder, Incoherent, Polycystic Ovaries, Menstrual Disorder after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Micropakine treatment in female patients, resulting in Delirium side effect.
Micropakine Side Effect Report#9916097
Ischaemic Stroke
This report suggests a potential Micropakine Ischaemic Stroke side effect(s) that can have serious consequences. A 78-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Micropakine (dosage: NA) starting 201310. After starting Micropakine the patient began experiencing various side effects, including: Ischaemic StrokeAdditional drugs used concurrently:
  • Zyprexa
  • Zyprexa
  • Ceris
  • Seresta
The patient was hospitalized. Although Micropakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Ischaemic Stroke, may still occur.
Micropakine Side Effect Report#9894081
Fracture, Fall
This Fracture problem was reported by a physician from FR. A 91-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Nov 21, 2013 this consumer started treatment with Micropakine (dosage: NA). The following drugs were being taken at the same time:
  • Xanax
  • Xanax
  • Effexor
  • Seresta
  • Dipiperon
  • Deroxat
  • Deroxat
  • Venlafaxine Hydrochloride
When using Micropakine, the patient experienced the following unwanted symptoms/side effects: Fracture, FallThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Fracture, may become evident only after a product is in use by the general population.
Micropakine Side Effect Report#9893889
Bronchopulmonary Aspergillosis, Pyrexia, Agranulocytosis
This Bronchopulmonary Aspergillosis side effect was reported by a health professional from FR. A 19-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Micropakine (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Micropakine the consumer reported adverse symptoms, such as: Bronchopulmonary Aspergillosis, Pyrexia, AgranulocytosisThese side effects may potentially be related to Micropakine. The patient was hospitalized.
Micropakine Side Effect Report#9869934
Extrapyramidal Disorder, Dementia
This is a report of a 85-year-old female patient (weight: NA) from FR, suffering from the following health symptoms/conditions: NA, who was treated with Micropakine (dosage: NA, start time:
Nov 08, 2013), combined with: NA. and developed a serious reaction and side effect(s): Extrapyramidal Disorder, Dementia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Micropakine treatment in female patients, resulting in Extrapyramidal Disorder side effect. The patient was hospitalized.
Micropakine Side Effect Report#9850506
Lipase Increased, Vessel Puncture Site Haemorrhage, Gastrointestinal Haemorrhage, Hepatitis Fulminant
This report suggests a potential Micropakine Lipase Increased side effect(s) that can have serious consequences. A 3-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: severe myoclonic epilepsy of infancy and used Micropakine (dosage: NA) starting 2011. After starting Micropakine the patient began experiencing various side effects, including: Lipase Increased, Vessel Puncture Site Haemorrhage, Gastrointestinal Haemorrhage, Hepatitis FulminantAdditional drugs used concurrently:
  • Urbanyl
  • Paracetamol
  • Diacomit
  • Epitomax
  • Glucose
  • Thiopental
  • Midazolam Hydrochloride
The patient was hospitalized. Although Micropakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Lipase Increased, may still occur.
Micropakine Side Effect Report#9820984
Withdrawal Syndrome, Sleep Disorder, Hallucination
This Withdrawal Syndrome problem was reported by a health professional from FR. A 18-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: epilepsy. On 201308 this consumer started treatment with Micropakine (dosage: NA). The following drugs were being taken at the same time: NA. When using Micropakine, the patient experienced the following unwanted symptoms/side effects: Withdrawal Syndrome, Sleep Disorder, HallucinationAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Withdrawal Syndrome, may become evident only after a product is in use by the general population.
Micropakine Side Effect Report#9705375
Extrapyramidal Disorder
This Extrapyramidal Disorder side effect was reported by a health professional from FR. A 10-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Micropakine (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Seropram
  • Transipeg
.After starting to take Micropakine the consumer reported adverse symptoms, such as: Extrapyramidal DisorderThese side effects may potentially be related to Micropakine. The patient was hospitalized.
Micropakine Side Effect Report#9380851
Cyanosis, Petit Mal Epilepsy, Epilepsy
This is a report of a 6-year-old female patient (weight: NA) from BE, suffering from the following health symptoms/conditions: epilepsy, who was treated with Micropakine (dosage: NA, start time: NS), combined with:
  • Tegretol
  • Keppra
  • Saccharomyces Boulardii
and developed a serious reaction and side effect(s): Cyanosis, Petit Mal Epilepsy, Epilepsy after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Micropakine treatment in female patients, resulting in Cyanosis side effect.
Micropakine Side Effect Report#9374849
Dysphagia, Convulsion
This report suggests a potential Micropakine Dysphagia side effect(s) that can have serious consequences. A 6-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: convulsion and used Micropakine (dosage: 600 Milligram(s) ;daily) starting NS. After starting Micropakine the patient began experiencing various side effects, including: Dysphagia, ConvulsionAdditional drugs used concurrently: NA. Although Micropakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dysphagia, may still occur.
Micropakine Side Effect Report#9014536
Cerebellar Syndrome, Abnormal Behaviour, Speech Disorder, Gait Disturbance
This Cerebellar Syndrome problem was reported by a health professional from FR. A 3-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: convulsion,status epilepticus. On
Oct 23, 2012 this consumer started treatment with Micropakine L.p. (dosage: NA). The following drugs were being taken at the same time:
  • Urbanyl (Daily)
  • Rivotril
When using Micropakine L.p., the patient experienced the following unwanted symptoms/side effects: Cerebellar Syndrome, Abnormal Behaviour, Speech Disorder, Gait DisturbanceThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cerebellar Syndrome, may become evident only after a product is in use by the general population.
Micropakine Side Effect Report#8958130
Convulsion, Status Epilepticus
This Convulsion side effect was reported by a physician from FR. A 3-year-old male patient (weight:NA) experienced the following symptoms/conditions: convulsion.The patient was prescribed Micropakine L.p. (drug dosage: NA), which was initiated on 2010. Concurrently used drugs: NA..After starting to take Micropakine L.p. the consumer reported adverse symptoms, such as: Convulsion, Status EpilepticusThese side effects may potentially be related to Micropakine L.p.. The patient was hospitalized.
Micropakine Side Effect Report#8955150
Pulmonary Embolism
This is a report of a 25-year-old female patient (weight: NA) from FR, suffering from the following health symptoms/conditions: epilepsy, who was treated with Micropakine (dosage: NA, start time: NS), combined with:
  • Urbanyl
  • Stediril (1 Dosage Form Daily)
  • Lamotrigine (100mg Daily)
and developed a serious reaction and side effect(s): Pulmonary Embolism after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Micropakine treatment in female patients, resulting in Pulmonary Embolism side effect.
Micropakine Side Effect Report#8848941
Speech Disorder, Aphasia, Oppositional Defiant Disorder, Aggression, Overdose
This report suggests a potential Micropakine Speech Disorder side effect(s) that can have serious consequences. A 10-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: partial seizures and used Micropakine (dosage: NA) starting
Apr 27, 2012. After starting Micropakine the patient began experiencing various side effects, including: Speech Disorder, Aphasia, Oppositional Defiant Disorder, Aggression, OverdoseAdditional drugs used concurrently: NA.The patient was hospitalized. Although Micropakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Speech Disorder, may still occur.
Micropakine Side Effect Report#8807477
Alanine Aminotransferase Increased, Gamma-glutamyltransferase Increased
This Alanine Aminotransferase Increased problem was reported by a health professional from FR. A 52-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On 2010 this consumer started treatment with Micropakine L.p. (dosage: Duration: Few Years). The following drugs were being taken at the same time:
  • Vimpat
When using Micropakine L.p., the patient experienced the following unwanted symptoms/side effects: Alanine Aminotransferase Increased, Gamma-glutamyltransferase IncreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Alanine Aminotransferase Increased, may become evident only after a product is in use by the general population.
Micropakine Side Effect Report#8685728
Convulsion
This Convulsion side effect was reported by a pharmacist from FR. A 60-year-old male patient (weight:NA) experienced the following symptoms/conditions: epilepsy.The patient was prescribed Micropakine (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Micropakine the consumer reported adverse symptoms, such as: ConvulsionThese side effects may potentially be related to Micropakine. The patient was hospitalized.
Micropakine Side Effect Report#7419316-X
Apathy, Abdominal Pain, Urinary Incontinence, Hallucination, Vitamin B12 Deficiency, Alopecia
This is a report of a 9-year-old female patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Micropakine L.p. Prolonged Release Granules (dosage: NA, start time:
Jan 14, 2010), combined with: NA. and developed a serious reaction and side effect(s): Apathy, Abdominal Pain, Urinary Incontinence, Hallucination, Vitamin B12 Deficiency, Alopecia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Micropakine L.p. Prolonged Release Granules treatment in female patients, resulting in Apathy side effect.
Micropakine Side Effect Report#7270340-X
Menometrorrhagia
This report suggests a potential Micropakine Menometrorrhagia side effect(s) that can have serious consequences. A 22-year-old female patient (weight: NA) from France was diagnosed with the following symptoms/conditions: epilepsy and used Micropakine (dosage: NA) starting
Jan 01, 2008. After starting Micropakine the patient began experiencing various side effects, including: MenometrorrhagiaAdditional drugs used concurrently:
  • Rivotril
  • Keppra
  • Inovelon
  • Lutenyl
Although Micropakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Menometrorrhagia, may still occur.
Micropakine Side Effect Report#7180721-0
Ataxia, Fall
This Ataxia problem was reported by a health professional from France. A 2-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: epilepsy. On
Apr 01, 2010 this consumer started treatment with Micropakine L.p. (dosage: Daily). The following drugs were being taken at the same time:
  • Urbanyl (Daily)
  • Topiramate
When using Micropakine L.p., the patient experienced the following unwanted symptoms/side effects: Ataxia, FallThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Ataxia, may become evident only after a product is in use by the general population.
Micropakine Side Effect Report#6988633-X
Overdose, Vomiting
This Overdose side effect was reported by a health professional from France. A 16-year-old female patient (weight:NA) experienced the following symptoms/conditions: epilepsy.The patient was prescribed Micropakine Lp (drug dosage: Prolonged-release Granules; Twice A Day), which was initiated on
Aug 06, 2010. Concurrently used drugs: NA..After starting to take Micropakine Lp the consumer reported adverse symptoms, such as: Overdose, VomitingThese side effects may potentially be related to Micropakine Lp. The patient was hospitalized.
Micropakine Side Effect Report#6745642-3
Apathy, Product Quality Issue, Somnolence
This is a report of a 14-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: mental retardation, who was treated with Micropakine L.p. (dosage: NA, start time:
Jan 01, 2002), combined with: NA. and developed a serious reaction and side effect(s): Apathy, Product Quality Issue, Somnolence after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Micropakine L.p. treatment in male patients, resulting in Apathy side effect.
Micropakine Side Effect Report#6725780-1
Mouth Ulceration, Pruritus, Rash Maculo-papular, Toxic Skin Eruption
This report suggests a potential Micropakine Mouth Ulceration side effect(s) that can have serious consequences. A 6-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: epilepsy,ear infection and used Micropakine (dosage: Prolonged-release Granules) starting
Apr 21, 2010. After starting Micropakine the patient began experiencing various side effects, including: Mouth Ulceration, Pruritus, Rash Maculo-papular, Toxic Skin EruptionAdditional drugs used concurrently:
  • Rocephin
  • Nureflex
  • Prodilantin
  • Prodilantin
  • Rivotril
  • Rivotril
  • Urbanyl
  • Tegretol
The patient was hospitalized. Although Micropakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Mouth Ulceration, may still occur.
Micropakine Side Effect Report#6672475-9
Hepatitis Cholestatic
This Hepatitis Cholestatic problem was reported by a health professional from France. A 87-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: epilepsy. On NS this consumer started treatment with Micropakine L. P. (dosage: NA). The following drugs were being taken at the same time:
  • Bisoprolol Fumarate
  • Temesta
  • Coumadin
  • Cetornan
When using Micropakine L. P., the patient experienced the following unwanted symptoms/side effects: Hepatitis CholestaticThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hepatitis Cholestatic, may become evident only after a product is in use by the general population.
Micropakine Side Effect Report#6174666-2
Accidental Overdose, Altered State Of Consciousness, Vomiting
This Accidental Overdose side effect was reported by a pharmacist from France. A 4-year-old female patient (weight:NA) experienced the following symptoms/conditions: epilepsy.The patient was prescribed Micropakine Granule (drug dosage: 1000 Mg), which was initiated on
Apr 14, 2009. Concurrently used drugs: NA..After starting to take Micropakine Granule the consumer reported adverse symptoms, such as: Accidental Overdose, Altered State Of Consciousness, VomitingThese side effects may potentially be related to Micropakine Granule. The patient was hospitalized.
Micropakine Side Effect Report#6066508-0
Epilepsy, Liver Disorder
This is a report of a 14-year-old female patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Micropakine (dosage: NA, start time:
Jul 01, 2008), combined with: NA. and developed a serious reaction and side effect(s): Epilepsy, Liver Disorder after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Micropakine treatment in female patients, resulting in Epilepsy side effect.


1 of 2 


The appearance of Micropakine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Micropakine Side Effects for Women?

Women Side Effects Reports
Epilepsy 4
C-reactive Protein Increased 3
Hallucination 3
Pancytopenia 3
Rash Morbilliform 3
Systemic Inflammatory Response Syndrome 3
Accidental Overdose 2
Klebsiella Infection 2
Myelodysplastic Syndrome 2
Overdose 2

What are common Micropakine Side Effects for Men?

Men Side Effects Reports
Convulsion 5
Epilepsy 5
Pancreatitis Acute 2
Somnolence 2
Status Epilepticus 2
Treatment Noncompliance 2
Abnormal Behaviour 1
Adenoidectomy 1
Agranulocytosis 1
Alanine Aminotransferase Increased 1

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Micropakine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Micropakine Side Effects

    Did You Have a Micropakine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Micropakine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Micropakine Safety Alerts, Active Ingredients, Usage Information

    More About Micropakine

    Side Effects reported to FDA: 47

    Micropakine safety alerts: No

    Reported deaths: 4

    Reported hospitalizations: 15

    Latest Micropakine clinical trials

    Micropakine Reviews

    No reviews, be a first to report a side effect via side effect reporting form